Jtekt India Q1 FY27: PAT falls 42% YoY, margins compress despite 27% revenue growth
PAT -42.48% YoY · revenue +26.85% · margins compressing
₹717.98 Cr
+26.85% YoY
₹6.22 Cr
-42.48% YoY
0.86%
-1pp YoY
₹0.22
Jtekt India's standalone Q1 FY27 (quarter ended 30 June 2026) results show a sharp profitability squeeze even as the topline grew: revenue from operations rose 26.9% YoY to ₹717.98 Cr (from ₹566.02 Cr in Q1 FY26), but net profit fell 42.5% YoY to ₹6.22 Cr (from ₹10.82 Cr), with EPS down to ₹0.22 from ₹0.42. Sequentially the decline is sharper still — PAT is down 77.4% QoQ from ₹27.49 Cr, even though revenue slipped a more modest 8.0% QoQ from ₹780.33 Cr, underlining this is a margin story rather than a demand story. No exceptional items hit either the current or year-ago quarter, so the decline is entirely operational rather than a one-off distortion.
Q1 FY-2027 vs prior quarters
The margin bridge points to costs running ahead of revenue: net profit margin compressed to ~0.87% of total income from 1.88% YoY and 3.51% QoQ, while EBIT margin (profit before exceptional items and tax, over revenue) fell to 1.20% from 2.57% YoY and 5.24% QoQ. Employee benefit expense rose 21.0% YoY and 18.3% QoQ to ₹80.93 Cr — the single largest swing factor, moving opposite to the revenue trend in both comparisons. Materials cost also crept up to 72.8% of revenue versus 71.0-72.0% in the comparison quarters, a modest mix drag. Depreciation (+34.9% YoY to ₹28.31 Cr) and finance costs (+23.8% YoY to ₹5.20 Cr) both rose faster than revenue, consistent with new production lines the company has been commissioning using rights-issue proceeds.
The stock went into the print at ₹133.16, down 6.2% over the past month of trading.
What the summary numbers don't show
No exceptional items this quarter (vs ₹2.45 Cr exceptional gratuity charge in Q4 FY26); results are unaudited, reviewed by B S R & Co. LLP.
Management is optimistic about continued revenue growth, expecting to add approximately INR 800 crores in the next year through a combination of market growth and increased export business. They anticipate full capacity utilization for newly commissioned lines within the next 1 to 1.5 years, leading to improved ROCE. W
— This quarter: missed
Against management's own May 2026 guidance — continued revenue growth toward ~₹800 Cr of annual additions, full utilisation of new lines within 1-1.5 years improving ROCE, and near-term margin pressure from product mix/accounting issues expected to normalise — this quarter is mixed: revenue growth of 26.9% YoY is broadly on the pace management flagged, but the margin pressure has not normalised — it has worsened both YoY and QoQ, so the quarter reads as a miss on the margin leg of that guidance. No specific street consensus estimates for this quarter were found (a Univest preview flagged raw-material cost volatility as a key margin risk without giving a PAT figure), so vs-street is unknown. The 2 July exchange clarification on 'volume surge, market driven factors' aligns with the strong YoY revenue print but does not explain the cost side. Separately, the board has set 7 August as record date and 26 August as AGM date for the ₹0.75/share FY26 final dividend already approved in May; the company also received a ₹622.39 demand notice for MEIS scrips on 4 August, a tax matter not reflected as an exceptional item in this statement. No standalone management press release beyond the exchange filing was available to cross-check management's own framing of the quarter.
W1
Employee cost ratio (11.3% of revenue this quarter) — watch for reversion toward the 8.8-11.8% range seen in the comparison quarters as new lines ramp up.
W2
Materials cost ratio (72.8% of revenue) — management guided margin improvement from higher-value CVJ/export mix; watch for reversion toward Q4 FY26's 71.0%.
W3
Progress toward full utilisation of newly commissioned lines (guided 1-1.5 years from May 2026) and the associated ROCE improvement management flagged.
Informational and educational content only. Not investment advice.